European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
Date: September 25, 2023
The EMA has opened a public consultation on a reflection paper presenting views on artificial intelligence and machine learning at any step of the lifecycle of human and veterinary medicines, from drug discovery to the post-authorisation setting.
All interested stakeholders are invited to comment on the draft reflection paper and to identify opportunities and risks of AI in the field of medicines – deadline: 31 December 2023
The topic will be further discussed during a joint HMA/EMA workshop scheduled for 20-21 November 2023.
The feedback from stakeholders will be analysed and considered for the finalisation of the reflection paper and future development of guidance as relevant.
Find out more here.
Explore More News
Launch of Online Training from ACDM
The Association for Clinical Data Management is delighted to announce the launch of Online . . .
Read More
ACDM 2019 Awards Finalists
The Association for Clinical Data Management are delighted to announce the finalists for . . .
Read More
Castor EDC to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that Castor . . .
Read More
Danone Nutricia Research to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that . . .
Read More
ACDM19 Conference Programme
The Association for Clinical Data Management is delighted to announce the Full Programme . . .
Read More
Record Number of Abstracts Submitted for ACDM19
The deadline for Abstracts for ACDM19 passed on the 30th September and the Association for . . .
Read More
Phastar Sponsor ACDM19
The Association for Clinical Data Management are delighted to announce that PHASTAR are . . .
Read More
Launch of Annual ACDM Awards
The Association for Clinical Data Management are delighted to announce the introduction of . . .
Read More
